Saturday, Sep 6, 2025
Search
Hyderabad
Telangana
AP News
India
World
Entertainment
Sport
Science and Tech
Business
Rewind
...
NRI
View Point
cartoon
My Space
Olympics
Education Today
Reviews
Property
Lifestyle
E-Paper
NRI
View Point
cartoon
My Space
Reviews
Education Today
Property
Lifestyle
"b-1-617-2-delta-variant"
Phase 3 trial data shows Covaxin to be 77.8% effective against Covid-19
Efficacy data also demonstrates 65.2 per cent protection against the SARS-CoV-2, B.1.617.2 Delta variant, the company said in a statement while announcing its phase 3 data analysis.
Latest News
62nd National Chess Championship to be held in Guntur
33 mins ago
India begins critical minerals’ journey to strengthen supply chain resilience
1 hour ago
Hyderabad: Richmond Villas Ganesh laddu auctioned for record Rs 2.32 crore
8 mins ago
Vedanta’s takeover of Jaiprakash Associates raises concerns over SLBC tunnel project
2 hours ago
Horoscope: Find out your star predictions today, Sept 6, 2025
2 hours ago
Bengaluru devotee donates over Rs 1 crore to TTD’s health scheme
2 hours ago
Manoj Manchu all set for a fierce comeback with Mirai
2 hours ago
Balapur Ganesh laddu fetches record Rs 35 lakh at auction
54 mins ago
.